mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
5e-11 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-09 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |